BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 31072572)

  • 1. Galectin-3 Levels and Outcomes After Myocardial Infarction: A Population-Based Study.
    Asleh R; Enriquez-Sarano M; Jaffe AS; Manemann SM; Weston SA; Jiang R; Roger VL
    J Am Coll Cardiol; 2019 May; 73(18):2286-2295. PubMed ID: 31072572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community Perspective.
    Jenkins WS; Roger VL; Jaffe AS; Weston SA; AbouEzzeddine OF; Jiang R; Manemann SM; Enriquez-Sarano M
    Am J Med; 2017 Sep; 130(9):1112.e9-1112.e15. PubMed ID: 28344136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of Galectin-3 for the occurrence of coronary artery disease and prognosis after myocardial infarction and its association with carotid IMT values in these patients: A mid-term prospective cohort study.
    Lisowska A; Knapp M; Tycińska A; Motybel E; Kamiński K; Święcki P; Musiał WJ; Dymicka-Piekarska V
    Atherosclerosis; 2016 Mar; 246():309-17. PubMed ID: 26828748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality Associated With Heart Failure After Myocardial Infarction: A Contemporary Community Perspective.
    Gerber Y; Weston SA; Enriquez-Sarano M; Berardi C; Chamberlain AM; Manemann SM; Jiang R; Dunlay SM; Roger VL
    Circ Heart Fail; 2016 Jan; 9(1):e002460. PubMed ID: 26699392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherosclerotic Burden and Heart Failure After Myocardial Infarction.
    Gerber Y; Weston SA; Enriquez-Sarano M; Manemann SM; Chamberlain AM; Jiang R; Roger VL
    JAMA Cardiol; 2016 May; 1(2):156-62. PubMed ID: 27437886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community.
    Ho JE; Liu C; Lyass A; Courchesne P; Pencina MJ; Vasan RS; Larson MG; Levy D
    J Am Coll Cardiol; 2012 Oct; 60(14):1249-56. PubMed ID: 22939561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary Risk Stratification After Myocardial Infarction in the Community: Performance of Scores and Incremental Value of Soluble Suppression of Tumorigenicity-2.
    Gerber Y; Weston SA; Enriquez-Sarano M; Jaffe AS; Manemann SM; Jiang R; Roger VL
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29054840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating systemic fibrosis by combining galectin-3 and ST2 provides powerful risk stratification value for patients after acute decompensated heart failure.
    Wang CH; Yang NI; Liu MH; Hsu KH; Kuo LT
    Cardiol J; 2016; 23(5):563-572. PubMed ID: 27515479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal function largely influences Galectin-3 prognostic value in heart failure.
    Zamora E; Lupón J; de Antonio M; Galán A; Domingo M; Urrutia A; Troya M; Bayes-Genis A
    Int J Cardiol; 2014 Nov; 177(1):171-7. PubMed ID: 25499371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Galectin-3 and Soluble ST2, and Their Changes, with Echocardiographic Parameters and Development of Heart Failure after ST-Segment Elevation Myocardial Infarction.
    Tymińska A; Kapłon-Cieślicka A; Ozierański K; Budnik M; Wancerz A; Sypień P; Peller M; Balsam P; Opolski G; Filipiak KJ
    Dis Markers; 2019; 2019():9529053. PubMed ID: 31687050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophilia predicts death and heart failure after myocardial infarction: a community-based study.
    Arruda-Olson AM; Reeder GS; Bell MR; Weston SA; Roger VL
    Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):656-62. PubMed ID: 20031905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proenkephalin and prognosis after acute myocardial infarction.
    Ng LL; Sandhu JK; Narayan H; Quinn PA; Squire IB; Davies JE; Bergmann A; Maisel A; Jones DJ
    J Am Coll Cardiol; 2014 Jan; 63(3):280-9. PubMed ID: 24140658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of galectin-3 on admission in Chinese patients with heart failure: a prospective observational study.
    Wang H; Chen Q; Li Y; Jing X; Liang T; Yang J
    Acta Cardiol; 2017 Apr; 72(2):188-195. PubMed ID: 28597803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Serial Measurements of Soluble Suppression of Tumorigenicity 2 and Galectin-3 in Ambulatory Patients With Chronic Heart Failure.
    Miller WL; Saenger AK; Grill DE; Slusser JP; Bayes-Genis A; Jaffe AS
    J Card Fail; 2016 Apr; 22(4):249-55. PubMed ID: 26277907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden cardiac arrest and ventricular arrhythmias following first type I myocardial infarction in the contemporary era.
    Amin M; Kella D; Killu AM; Padmanabhan D; Hodge DO; Golafshar MA; Chamberlain AM; Lee JZ; Shen WK; Friedman PA; Asirvatham SJ; Roger VL; Gersh BJ; Mulpuru SK
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2869-2876. PubMed ID: 31588605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic profile provides prognostic value better than galectin-3 in patients with heart failure.
    Wang CH; Cheng ML; Liu MH; Kuo LT; Shiao MS
    J Cardiol; 2017 Jul; 70(1):92-98. PubMed ID: 28318874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sudden death after myocardial infarction.
    Adabag AS; Therneau TM; Gersh BJ; Weston SA; Roger VL
    JAMA; 2008 Nov; 300(17):2022-9. PubMed ID: 18984889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial.
    Ferreira JP; Sharma A; Mehta C; Bakris G; Rossignol P; White WB; Zannad F
    Clin Res Cardiol; 2021 Jul; 110(7):1006-1019. PubMed ID: 32789678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between galectin-3 and clinical parameters in patients with first acute myocardial infarction treated with primary percutaneous coronary angioplasty.
    Szadkowska I; Wlazeł RN; Migała M; Szadkowski K; Zielińska M; Paradowski M; Pawlicki L
    Cardiol J; 2013; 20(6):577-82. PubMed ID: 24338533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.